Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-048461

Pres. & Chief Exec. Officer sold 4,172 shares at $22.92 ($95,622)

  • Pres. & Chief Exec. Officer acquired 550 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Option exercise 10b5-1 +550 $2.39 $1,315 22,029 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Sale 10b5-1 −550 $22.92 $12,606 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Sale 10b5-1 −1,357 $22.92 $31,102 39,353 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Sale 10b5-1 −1,153 $22.92 $26,427 33,449 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Sale 10b5-1 −278 $22.92 $6,372 12,090 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Sale 10b5-1 −278 $22.92 $6,372 12,090 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Sale 10b5-1 −278 $22.92 $6,372 12,090 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Sale 10b5-1 −278 $22.92 $6,372 12,090 I
Derivatives
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-07-14 Option exercise · Stock option (right to buy) 10b5-1 −550 85,117 D
Open-market sales · 4,172 sh · avg $22.92 · $95,622
Loading xslF345X06/wk-form4_1784232967.xml…